AFLAC Incorporated with ticker code (AFL) have now 13 analysts in total covering the stock. The consensus rating is ‘Hold’. The range between the high target price and low target price is between 74 and 54 and has a mean target at 66.62. Now with the previous closing price of 70.59 this would imply there is a potential downside of -5.6%. The 50 day MA is 62.19 and the 200 day MA is 60.52. The market capitalisation for the company is $44,110m. Company Website: https://www.aflac.com
The potential market cap would be $41,629m based on the market concensus.
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.
